Home>Topics>>Teva files a citizen petition regarding approvability of generic versions of Copaxone

Teva files a citizen petition regarding approvability of generic versions of Copaxone

SeekingAlpha.com: SA Currents

Thu, 3 Jul 2014

In response to a request from the FDA , ( TEVA ) files a citizen petition (CP) on the approvability of generic versions of Copaxone (glatiramer acetate injection). The agency wanted a CP in order to facilitate public review and comment on new scientific data on gene expression. This will allow Teva ...

Related Videos

  1. Prescribe to Pharma for Emerging-Markets Growth

    Thu, 12 Dec 2013

    Many developed-country health-care firms have deep roots in emerging markets and can be a good way to gain exposure, says Morningstar's Damien Conover.

Content Partners